BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3287749)

  • 21. Emergence of antibiotic resistance amongst hospital-acquired urinary tract infections and pharmacokinetic/pharmacodynamic considerations.
    Wagenlehner FM; Weidner W; Naber KG
    J Hosp Infect; 2005 Jul; 60(3):191-200. PubMed ID: 15893853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aztreonam versus cefamandole in the treatment of urinary tract infections.
    Giamarellou H; Koratzanis G; Kanellakopoulou K; Galanakis N; Papoulias G; el Messidi M; Daikos G
    Chemioterapia; 1984 Apr; 3(2):127-31. PubMed ID: 6543431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Etiologic agents and risk factors in nosocomial urinary tract infections].
    Akkoyun S; Kuloğlu F; Tokuç B
    Mikrobiyol Bul; 2008 Apr; 42(2):245-54. PubMed ID: 18697422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bacteriologic diagnosis and antibiotic therapy of urinary tract infections].
    Caron F
    Rev Prat; 2003 Oct; 53(16):1760-9. PubMed ID: 14702817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Epidemiology and pathogen spectrum of urinary tract infections].
    Breyer S; Feistauer SM; Burgmann H; Georgopoulos M; Georgopoulos A
    Wien Med Wochenschr; 1991; 141(23-24):533-6. PubMed ID: 1810091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Problem pathogens in nosocomial infections of urinary tract.
    Resnick MI
    Urology; 1985 Jul; 26(1 Suppl):5-7. PubMed ID: 3892855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Urinary tract infections in a general medicine department. Comments on cases collected over 3 years].
    Arosio A; Ferrari S; Tranchina G; Borroni M; Grassi L
    Minerva Med; 1986 Jul; 77(28-29):1339-46. PubMed ID: 3736970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of the effectiveness of ceftazidime in treatment of nosocomial infections in children].
    Czerwionka-Szaflarska M; Sobkowiak E
    Pediatr Pol; 1996 Jul; 71(7):605-7. PubMed ID: 8803464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic resistance patterns in children hospitalized for urinary tract infections.
    Lutter SA; Currie ML; Mitz LB; Greenbaum LA
    Arch Pediatr Adolesc Med; 2005 Oct; 159(10):924-8. PubMed ID: 16203936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary tract infections in the elderly.
    McCue JD
    Pharmacotherapy; 1993; 13(2 Pt 2):51S-53S. PubMed ID: 8474939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
    Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
    Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resistance in gram-negative bacteria: enterobacteriaceae.
    Paterson DL
    Am J Med; 2006 Jun; 119(6 Suppl 1):S20-8; discussion S62-70. PubMed ID: 16735147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Aztreonam: monocenter microbiological study with prevention experience in surgery].
    Malcangi A; Pesce S; Vitale M; Martinetto P
    G Batteriol Virol Immunol; 1987; 80(1-12):237-51. PubMed ID: 3509031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections: a prospective study.
    Sotto A; De Boever CM; Fabbro-Peray P; Gouby A; Sirot D; Jourdan J
    J Clin Microbiol; 2001 Feb; 39(2):438-44. PubMed ID: 11158087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of aztreonam against other antibiotics used in urinary tract infections.
    Khan MT; Shah SH
    J Ayub Med Coll Abbottabad; 2001; 13(4):22-4. PubMed ID: 11873424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic resistance in children with recurrent or complicated urinary tract infection.
    Younis N; Quol K; Al-Momani T; Al-Awaisheh F; Al-Kayed D
    JNMA J Nepal Med Assoc; 2009; 48(173):14-9. PubMed ID: 19529052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bacterial nosocomial infections in urology: nosocomial urinary tract infections].
    Porpaczy P; Schmidbauer CP
    Wien Klin Wochenschr; 1982 Apr; 94(9):235-40. PubMed ID: 6181619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bacterial pathogens, resistance patterns and treatment options in community acquired pediatric urinary tract infection].
    Pape L; Gunzer F; Ziesing S; Pape A; Offner G; Ehrich JH
    Klin Padiatr; 2004; 216(2):83-6. PubMed ID: 15106080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Spectrum of pathogens and resistance to antibiotics in urinary tract infections and the consequences for antibiotic treatment: study of urology inpatients with urinary tract infections (1994-2001)].
    Wagenlehner E; Niemetz A; Naber G
    Urologe A; 2003 Jan; 42(1):13-25. PubMed ID: 12574879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Aztreonam--new antibiotic for treating infections caused by gram-negative aerobic bacteria].
    Szymkowiak J; Fojt E
    Wiad Lek; 1993; 46(1-2):56-61. PubMed ID: 8249381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.